Reports for ATORVASTATIN

Ingredient

ATORVASTATIN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-ATORVASTATIN 10MG TABLET Resolved 2024-01-29 2024-01-30 217690
MINT-ATORVASTATIN 20MG TABLET Resolved 2024-01-29 2024-01-30 217693
MINT-ATORVASTATIN 40MG TABLET Resolved 2024-01-29 2024-01-30 217696
MYLAN-AMLODIPINE/ATORVASTATIN 40MG 5MG TABLET Resolved 2025-06-17 2025-07-21 260513
MYLAN-AMLODIPINE/ATORVASTATIN 80MG 5MG TABLET Resolved 2025-04-23 2025-07-21 255415
MYLAN-AMLODIPINE/ATORVASTATIN 40MG 10MG TABLET Resolved 2025-07-09 2025-07-21 262287
MYLAN-AMLODIPINE/ATORVASTATIN 80MG 10MG TABLET Resolved 2024-01-30 2024-08-27 217876
MYLAN-ATORVASTATIN 10MG TABLET Avoided shortage 2018-07-31 2018-10-09 57023
MYLAN-ATORVASTATIN 20MG TABLET Resolved 2017-10-13 2018-10-16 25898
MYLAN-ATORVASTATIN 40MG TABLET Avoided shortage 2017-06-02 2018-10-16 11785

Showing 131 to 140 of 274

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ATORVASTATIN 80MG TABLET Reversed 2025-05-28 2025-06-04 258655

Showing 51 to 51 of 51